01 Advancement of Minimally Invasive Surgical Methods The plastic surgery equipment market is witnessing significant growth driven by the advancement of minimally invasive surgical techniques. These methods, which include procedures such as endoscopic surgeries, laparoscopic techniques, and the use of laser systems, are becoming increasingly popular due to their advantages, such as shorter recovery times, minimal scarring, and reduced postoperative pain. For instance, the American Society of Plastic Surgeons (ASPS) released the 2023 ASPS Procedural Statistics, revealing a 7% increase in minimally invasive procedures compared to the previous year. Moreover, neuromodulator injections, such as Botox and dermal fillers, are minimally invasive surgical methods that have become essential components of aesthetic maintenance, offering almost immediate results with minimal recovery time. For instance, in September 2023, the American Society of Plastic Surgeons reported 4,715,716 procedures using botulinum toxin type A, a 6% increase from the previous year, and 3,441,534 dermal filler procedures, reflecting a 4% rise compared to 2022. This trend reflects a broader shift in the healthcare landscape, where precision and patient comfort are prioritized.
April 2026 Halma completed the acquisition of Surgistar, Inc. through its MicroSurgical Technology (MST) business, expanding its portfolio of precision surgical instruments and strengthening manufacturing capabilities for microsurgical and plastic surgery procedures.
March 2026 Vicarious Surgical successfully completed integrated benchtop testing of its full suite of surgical instruments, including needle drivers, fenestrated graspers, and monopolar scissors, advancing the development of robotic-assisted minimally invasive surgical systems applicable to reconstructive and plastic surgery.
March 2026 Intuitive completed the acquisition of the da Vinci and Ion distribution business operated by ab medica and its affiliates in Southern Europe, expanding direct commercial operations and strengthening access to advanced robotic surgical instruments across the region.
September 2025 Oertli Instrumente launched the OS 4 Up surgical platform for cataract and vitreoretinal procedures, expanding its precision microsurgical instrument portfolio and improving workflow for ophthalmic surgeons.